Clinical Trials Logo

Clinical Trial Summary

Limited mobility of the uterine cervix and alignment with the vaginal canal is often required during insertion of an intrauterine contraceptive device (IUD). Currently, the available instruments are traumatic tenacula, which could cause pain and bleeding and therefore represent an obstacle for certain patients to pursue their medical follow-up. AspivixTM is a new device, which enables atraumatic traction of the cervix while respecting its specific semi-circular anatomic shape through a system powered by a vacuum chamber. The aim of our pilot study is to assess the usability, safety and efficacy of the device. Note: Study is made of 2 phases (pilot phase followed by a comparative phase). Details regarding comparative study is registered separately.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04441333
Study type Interventional
Source Aspivix SA
Contact
Status Completed
Phase N/A
Start date July 1, 2020
Completion date December 2, 2020

See also
  Status Clinical Trial Phase
Completed NCT02708251 - Glyceryl Trinitrate Versus Lidocaine Cream for IUD Insertion Phase 4
Completed NCT02141321 - Sub Lingual Misoprostol Before IUD Insertion in Women With Only Previous Cesarean Section Phase 2/Phase 3
Not yet recruiting NCT03473717 - Comparison of Pain Level During Intrauterine Device (IUD) Insertion Between Conventional and Direct Method N/A
Recruiting NCT05204979 - Vaginal Vs Subling Misoprost Before Iud Insertion in Women With Previous CS
Completed NCT02738203 - Self-Administered Lidocaine Gel for Pain Management With IUD Insertion Phase 3
Completed NCT02904915 - Paracervical Block Versus No Paracervical Block During IUD Insertion Phase 4
Completed NCT04046302 - Vaginal Dinoprostone Administration Prior to an Intrauterine Device Insertion in Multiparous Women. Phase 4
Completed NCT04441281 - Usability, Safety and Efficacy of AspivixTM (Comparative Study) N/A